These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Minactivin expression in human monocyte and macrophage populations. Stephens RW, Golder JP, Fayle DR, Hume DA, Hapel AJ, Allan W, Fordham CJ, Doe WF. Blood; 1985 Aug; 66(2):333-7. PubMed ID: 3926024 [Abstract] [Full Text] [Related]
4. Poly-D-lysine dependent inactivation of tissue plasminogen activator by a class PAI-2 inhibitor (minactivin). Leung KC, Byatt JA, Stephens RW. Thromb Res; 1987 Jun 15; 46(6):767-77. PubMed ID: 3114909 [Abstract] [Full Text] [Related]
5. Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme. Andreasen PA, Nielsen LS, Kristensen P, Grøndahl-Hansen J, Skriver L, Danø K. J Biol Chem; 1986 Jun 15; 261(17):7644-51. PubMed ID: 3086313 [Abstract] [Full Text] [Related]
6. Novel properties of human monocyte plasminogen activator. Stephens RW, Golder JP. Eur J Biochem; 1984 Mar 01; 139(2):253-8. PubMed ID: 6199200 [Abstract] [Full Text] [Related]
7. Monoclonal antibodies inhibitory to human plasmin. Definitive demonstration of a role for plasmin in activating the proenzyme of urokinase-type plasminogen activator. Sim PS, Fayle DR, Doe WF, Stephens RW. Eur J Biochem; 1986 Aug 01; 158(3):537-42. PubMed ID: 2942403 [Abstract] [Full Text] [Related]
14. A cyclopeptidic suicide substrate preferentially inactivates urokinase-type plasminogen activator. Reboud-Ravaux M, Vilain AC, Boggetto N, Maillard J, Favreau C, Xie J, Mazaleyrat JP, Wakselman M. Biochem Biophys Res Commun; 1991 Jul 15; 178(1):352-9. PubMed ID: 1829886 [Abstract] [Full Text] [Related]
15. Inhibition of cancer cell urokinase plasminogen activator by its specific inhibitor PAI-2 and subsequent effects on extracellular matrix degradation. Baker MS, Bleakley P, Woodrow GC, Doe WF. Cancer Res; 1990 Aug 01; 50(15):4676-84. PubMed ID: 2114945 [Abstract] [Full Text] [Related]
16. Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitor. Pöllänen J, Vaheri A, Tapiovaara H, Riley E, Bertram K, Woodrow G, Stephens RW. Proc Natl Acad Sci U S A; 1990 Mar 01; 87(6):2230-4. PubMed ID: 2138329 [Abstract] [Full Text] [Related]
18. Comparative studies on human activators of plasminogen. Mackie M, Booth NA, Bennett B. Br J Haematol; 1981 Jan 01; 47(1):77-90. PubMed ID: 6449216 [Abstract] [Full Text] [Related]
19. Receptor for plasmin on human carcinoma cells. Burtin P, Fondaneche MC. J Natl Cancer Inst; 1988 Jul 20; 80(10):762-5. PubMed ID: 2838642 [Abstract] [Full Text] [Related]
20. Platelet release protein which inhibits plasminogen activators. Booth NA, Anderson JA, Bennett B. J Clin Pathol; 1985 Jul 20; 38(7):825-30. PubMed ID: 3926830 [Abstract] [Full Text] [Related] Page: [Next] [New Search]